FDA Inspection 1037711 — Vitalant

Vitalant — FEI 1771468

The FDA completed an inspection of Vitalant on Dec 7, 2017 in Rapid City, SD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 7, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rapid City, SD (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.